Legato Capital Management’s Biodesix BDSX Stock Holding History

Legato Capital Management’s Portfolio BDSX Stock Details BDSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$597K	Buy	+41,174	New	+$510K	0.05%	498
2024 Q4	–	Sell	-16,716	Closed	-$595K	–	573
2024 Q3	$595K	Hold	16,716	–	–	0.07%	416
2024 Q2	$511K	Hold	16,716	–	–	0.07%	435
2024 Q1	$478K	Hold	16,716	–	–	0.06%	449
2023 Q4	$615K	Hold	16,716	–	–	0.08%	373
2023 Q3	$552K	Sell	16,716 -982	-6%	-$27.3K	0.08%	377
2023 Q2	$435K	Buy	17,698 +7,445	+73%	+$223K	0.06%	452
2023 Q1	$381K	Buy	10,253 +8,655	+542%	+$355K	0.07%	392
2022 Q4	$73.5K	Buy	+1,598	New	+$43.4K	0.01%	482

Other funds holding BDSX

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

TAM

Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return

Legato Capital Management's BDSX Position: Q1 2026 in Review

Legato Capital Management opened a new position in Biodesix (BDSX) in Q1 2026: 41,174 shares worth $597K. The stake represents 0.05% of the portfolio and ranks #498 among its holdings. This is a return to the name: Legato Capital Management previously reported a position in BDSX as recently as Q3 2024.

Legato Capital Management first reported a position in BDSX in Q4 2022 and has held it in 9 quarters since. The position peaked at $615K in Q4 2023. 40 funds tracked by Wall St. Rank hold BDSX as of Q1 2026.

Legato Capital Management held 41,174 shares of Biodesix worth $597K as of Q1 2026.
Biodesix was a new Legato Capital Management position in Q1 2026.
Biodesix made up 0.05% of Legato Capital Management's portfolio in Q1 2026, its #498 holding.
Legato Capital Management first reported a position in Biodesix in Q4 2022 and has held it in 9 quarters since.
Legato Capital Management's Biodesix position peaked at $615K in Q4 2023.
40 funds tracked by Wall St. Rank held Biodesix as of Q1 2026.

Based on Legato Capital Management's 13F filing for Q1 2026, filed 14 May 2026.